DePuy Synthes receives FDA clearance for robotic-assisted TKR solution
DePuy Synthes has received FDA 510(k) clearance of the Velys robotic-assisted total knee replacement solution for use with the Attune total knee system, according to a press release.
The robotic-assisted TKR solution is an addition to the Velys digital surgery platform and is designed to adapt and integrate into any OR to enhance surgeon workflow and improve outcomes, according to the release.
“Globally, previous generation robotics have only penetrated key orthopedic segments between 5% to 10% of the market. A significant opportunity for combined robotic and digital surgery technology exists. Coupled with the Attune total knee, the Velys robotic-assisted solution is highly differentiated and can help improve clinical outcomes and increase patient satisfaction, providing a more attractive clinical solution to current options on the market,” Aldo Denti, company group chair at DePuy Synthes, said in the release. “With the addition of the Velys robotic-assisted solution to our Velys digital surgery platform, we are continuing our vision to be the most personalized and connected orthopedics company,” he added.
Read more about